Patents by Inventor Franz Jakob Hock

Franz Jakob Hock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenosine analogues and their use as pharmaceutical agents
    Patent number: 7265111
    Abstract: The present invention relates to compounds according to the general formula (I) wherein X is selected from the group consisting of wherein n and p are independently 0, 1, 2, or 3, provided that n+p is a least 1; and unsubstituted and at least monosubstituted C1-C10-alkylene-Y, C2-C10-alkylene-Y, C3-C10-cycloalkylene-Y and C3-C10-cycloalkenylene-Y; and R1, A, B, Q, T, Y, E and W have the meanings given in the description. These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: September 4, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Antony Bigot, Siegfried Stengelin, Gerhard Jaehne, Andreas Herling, Guenter Mueller, Franz Jakob Hock, Michael R Myers
  • Novel adenosine analogues and their use as pharmaceutical agents
    Publication number: 20040127434
    Abstract: The present invention relates to compounds according to the general formula (I) 1
    Type: Application
    Filed: June 27, 2003
    Publication date: July 1, 2004
    Inventors: Antony Bigot, Siegfried Stengelin, Gerhard Jaehne, Andreas Herling, Guenter Mueller, Franz Jakob Hock, Michael R. Myers